Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0606920140220050414
Biomolecules & Therapeutics
2014 Volume.22 No. 5 p.414 ~ p.419
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-¥á Release from Activated Microglia and TNF-¥á Converting Enzyme Activity
Lee Eun-Jung

Moon Pyong-Gon
Baek Moon-Chang
Kim Hee-Sun
Abstract
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that regulate cell-matrix composition and are also involved in processing various bioactive molecules such as cell-surface receptors, chemokines, and cytokines. Our group recently reported that MMP-3, -8, and -9 are upregulated during microglial activation and play a role as proinflammatory mediators (Lee et al., 2010, 2014). In particular, we demonstrated that MMP-8 has tumor necrosis factor alpha (TNF-¥á)-converting enzyme (TACE) activity by cleaving the prodomain of TNF-¥á and that inhibition of MMP-8 inhibits TACE activity. The present study was undertaken to compare the effect of MMP-8 inhibitor (M8I) with those of inhibitors of other MMPs, such as MMP-3 (NNGH) or MMP-9 (M9I), in their regulation of TNF-¥á activity. We found that the MMP inhibitors suppressed TNF-¥á secretion from lipopolysaccharide (LPS)-stimulated BV2 microglial cells in an order of efficacy: M8I>NNGH>M9I. In addition, MMP inhibitors suppressed the activity of recombinant TACE protein in the same efficacy order as that of TNF-¥á inhibition (M8I>NNGH>M9I), proving a direct correlation between TACE activity and TNF-¥á secretion. A subsequent pro-TNF-¥á cleavage assay revealed that both MMP-3 and MMP-9 cleave a prodomain of TNF-¥á, suggesting that MMP-3 and MMP-9 also have TACE activity. However, the number and position of cleavage sites varied between MMP-3, -8, and -9. Collectively, the concurrent inhibition of MMP and TACE by NNGH, M8I, or M9I may contribute to their strong anti-inflammatory and neuroprotective effects.
KEYWORD
Microglia, Inflammation, MMP inhibitor, TNF-¥á, TACE
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed